Natures Pharmacy Recalls L-Glutathione Inhalation Due to Sterility Concerns
Natures Pharmacy & Compounding Center is recalling all lots of L-Glutathione inhalation due to quality control issues affecting sterility assurance.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II, and the hazard involves a lack of sterility assurance in a sterile product, which poses a significant risk of infection or serious injury.
Plain-English summary
Natures Pharmacy & Compounding Center is recalling all lots of L-Glutathione inhalation that are not expired. The recall was initiated due to concerns regarding quality control procedures that present a potential risk to sterility assurance.
These concerns were identified during a recent FDA inspection of the pharmacy. The recall covers all lots of sterile products compounded by the facility that are still within their expiration dates.
Consumers who have this product should stop using it and contact their healthcare provider or the pharmacy for further instructions.
The recalled product
- Product
- L-Glutathione inhalation
- Manufacturer
- Natures Pharmacy & Compounding Center
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lot numbers within expiry.
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 48 recalled by Natures Pharmacy & Compounding Center under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 48 products in this recall →Related recalls
Same manufacturer · Natures Pharmacy & Compounding Center
See all →- SevereNatures Pharmacy Recalls Triamcinolone Acetonide Due to Sterility Concerns
FDA (Drugs) · 2014-03-12
- SevereSodium Bicarbonate Injection Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2014-03-12
- SevereFDA Recalls Estradiol and Testosterone Compounds for Sterility Concerns
FDA (Drugs) · 2014-03-12
- SevereNatures Pharmacy Recalls Glutathione Inhalation Due to Sterility Concerns
FDA (Drugs) · 2014-03-12
- SevereNatures Pharmacy Recalls Voriconazole Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-03-12
Same hazard · sterility assurance
See all →- HighArrowhead DE LLC Recalls Arrow-LOK Implants Due to Sterility Assurance Concerns
FDA (Devices) · 2026-08-26
- SevereChloraPrep One-Step Applicators Recalled for Potential Packaging Seal Defects
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15
- SevereChloraPrep One-Step Applicators Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2026-07-08
- SevereArrow access trays and PSI kits contain recalled supplier drugs
FDA (Devices) · 2026-06-24